Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Aug 30;15(8):e29183.
doi: 10.5812/hepatmon.29183. eCollection 2015 Aug.

Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China

Affiliations

Low Serum Hepatitis B Surface Antigen Level Predicts Compensated Cirrhosis Caused by Chronic Hepatitis B in HBeAg Positive Patients in East China

Wen Jia et al. Hepat Mon. .

Abstract

Backgrounds: Serum hepatitis B surface antigen (HBsAg) levels are associated with fibrosis in patients with chronic hepatitis B (CHB) infection.

Objectives: The aim of our study was to evaluate serum HBsAg level as a biomarker for compensated cirrhosis in hepatitis B e antigen (HBeAg) positive CHB patients.

Patients and methods: Two-hundred and one HBeAg-positive Chinese CHB patients with or without cirrhosis were enrolled in this retrospective study. Cirrhosis was diagnosed based on liver biopsy. Furthermore, patients with decompensated cirrhosis were excluded. A statistical analysis was performed regarding the association between serum HBsAg level and compensated cirrhosis.

Results: Patients with compensated cirrhosis had a significantly lower mean serum HBsAg level compared to those without cirrhosis (3.27 Log10 IU/mL VS 4.17 Log10 IU/mL, P < 0.001). Furthermore, examining the correlation with compensated cirrhosis revealed that lower level of serum HBsAg was a significant factor in multivariate analysis. The area under the receiver operating characteristics curve of serum HBsAg was 0.856 for compensated cirrhosis. A positive predictive value of 66.2% and negative predictive value of 90.7% were obtained with a cut-off value of < 3.60 Log10 IU/mL (4000 IU/mL) of serum HBsAg. Moreover, the rate of compensated cirrhosis increased to 75.0% after combining with APRI > 2.

Conclusions: In HBeAg positive CHB patients, low serum HBsAg level is a useful predictor of compensated cirrhosis.

Keywords: Chronic; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B e Antigens; Liver Cirrhosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.. Flowchart of Study Participants
Abbreviations: CHB, chronic hepatitis B, HBsAg hepatitis B surface antigen.
Figure 2.
Figure 2.. The Differences in HBsAg Serum Levels for Different Stages of Fibrosis
Serum HBsAg were expressed as mean ± standard deviation, the results showed that serum HBsAg decreased with the process of fibrosis. There was a strong inverse correlation between serum HBsAg and fibrosis (r = -0.668, P < 0.001). Abbreviations: HBsAg, hepatitis B surface antigen.
Figure 3.
Figure 3.. The Differences in HBsAg Serum Levels Between CC Group and Non-Cirrhotic Group
CC group: patients with compensated cirrhosis; non-cirrhotic group: patients without cirrhosis.
Figure 4.
Figure 4.. Receiver Operating Characteristic Curves of Parameters in Predicting Compensated Cirrhosis
Abbreviations: HBsAg, hepatitis B surface antigen; and APRI, aspartate aminotransferase to platelet ratio index.
Figure 5.
Figure 5.. Rate of Compensated Cirrhosis Among Subgroups of Patients Stratified by HBsAg and APRI
Abbreviations: APRI, aspartate aminotransferase to platelet ratio index; and HBsAg, hepatitis B surface antigen.

Similar articles

Cited by

References

    1. Garcia–Tsao G. Current management of the complications of cirrhosis and portal hypertension: Variceal hemorrhage, ascites, and spontaneous bacterial peritonitis. Gastroenterology. 2001;120(3):726–48. doi: 10.1053/gast.2001.22580. - DOI - PubMed
    1. Butterworth RF. Complications of cirrhosis III. Hepatic encephalopathy. J Hepatol. 2000;32(1 Suppl):171–80. - PubMed
    1. Chu CM, Liaw YF. Hepatitis B virus-related cirrhosis: natural history and treatment. Semin Liver Dis. 2006;26(2):142–52. doi: 10.1055/s-2006-939752. - DOI - PubMed
    1. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003;23(1):47–58. doi: 10.1055/s-2003-37590. - DOI - PubMed
    1. European Association For The Study Of The L. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection. J Hepatol. 2012;57(1):167–85. doi: 10.1016/j.jhep.2012.02.010. - DOI - PubMed

LinkOut - more resources